416 related articles for article (PubMed ID: 16377707)
41. Trichomonas vaginalis prevalence, incidence, risk factors and antibiotic-resistance in an adolescent population.
Krashin JW; Koumans EH; Bradshaw-Sydnor AC; Braxton JR; Evan Secor W; Sawyer MK; Markowitz LE
Sex Transm Dis; 2010 Jul; 37(7):440-4. PubMed ID: 20351623
[TBL] [Abstract][Full Text] [Related]
42. Characterization of Giardia lamblia WB C6 clones resistant to nitazoxanide and to metronidazole.
Müller J; Sterk M; Hemphill A; Müller N
J Antimicrob Chemother; 2007 Aug; 60(2):280-7. PubMed ID: 17561498
[TBL] [Abstract][Full Text] [Related]
43. New chemotherapeutic nitroheterocycles active against 5-nitroimidazole-resistant strains of trichomonads.
Meingassner JG; Nesvadba H; Mieth H
Arzneimittelforschung; 1981; 31(1):6-8. PubMed ID: 6971111
[TBL] [Abstract][Full Text] [Related]
44. Management of trichomonas vaginalis in women with suspected metronidazole hypersensitivity.
Helms DJ; Mosure DJ; Secor WE; Workowski KA
Am J Obstet Gynecol; 2008 Apr; 198(4):370.e1-7. PubMed ID: 18221927
[TBL] [Abstract][Full Text] [Related]
45. Effects of metronidazole analogues on Giardia lamblia: experimental infection and cell organization.
Busatti HG; Alves RJ; Santana-Anjos KG; Gil FF; Cury MC; Vannier-Santos MA; Gomes MA
Diagn Microbiol Infect Dis; 2013 Feb; 75(2):160-4. PubMed ID: 23331963
[TBL] [Abstract][Full Text] [Related]
46. Drug susceptibility testing of anaerobic protozoa.
Upcroft JA; Upcroft P
Antimicrob Agents Chemother; 2001 Jun; 45(6):1810-4. PubMed ID: 11353630
[TBL] [Abstract][Full Text] [Related]
47. The modes of action of some anti-protozoal drugs.
Howells RE
Parasitology; 1985 Apr; 90 ( Pt 4)():687-703. PubMed ID: 3892438
[No Abstract] [Full Text] [Related]
48. Synergic effect of metronidazole and pyrantel pamoate on Giardia lamblia.
Hausen MA; Menna-Barreto RF; Lira DC; de Carvalho L; Barbosa HS
Parasitol Int; 2011 Jan; 60(1):54-8. PubMed ID: 20946968
[TBL] [Abstract][Full Text] [Related]
49. Chemoinformatic characterization of activity and selectivity switches of antiprotozoal compounds.
Aguayo-Ortiz R; Pérez-Villanueva J; Hernández-Campos A; Castillo R; Meurice N; Medina-Franco JL
Future Med Chem; 2014 Mar; 6(3):281-94. PubMed ID: 24279680
[TBL] [Abstract][Full Text] [Related]
50. Prevalence of 5-nitroimidazole-resistant trichomonas vaginalis in Oviedo, Spain.
Pérez S; Fernández-Verdugo A; Pérez F; Vázquez F
Sex Transm Dis; 2001 Feb; 28(2):115-6. PubMed ID: 11234785
[No Abstract] [Full Text] [Related]
51. In vitro effect of octenidine dihydrochloride against Trichomonas vaginalis.
Küng E; Pietrzak J; Klaus C; Walochnik J
Int J Antimicrob Agents; 2016 Mar; 47(3):232-4. PubMed ID: 26899578
[TBL] [Abstract][Full Text] [Related]
52. Inhibition of hydrogen production in drug-resistant and susceptible Trichomonas vaginalis strains by a range of nitroimidazole derivatives.
Lloyd D; Yarlett N; Yarlett NC
Biochem Pharmacol; 1986 Jan; 35(1):61-4. PubMed ID: 3000386
[No Abstract] [Full Text] [Related]
53. Isolation, excystation and axenization of Giardia lamblia isolates: in vitro susceptibility to metronidazole and albendazole.
Cruz A; Sousa MI; Azeredo Z; Leite E; Figueiredo de Sousa JC; Cabral M
J Antimicrob Chemother; 2003 Apr; 51(4):1017-20. PubMed ID: 12654760
[TBL] [Abstract][Full Text] [Related]
54. Pyridyl Methylsulfinyl Benzimidazole Derivatives as Promising Agents against
Hernández-Ochoa B; Martínez-Rosas V; Morales-Luna L; Calderón-Jaimes E; Rocha-Ramírez LM; Ortega-Cuellar D; Rufino-González Y; González-Valdez A; Arreguin-Espinosa R; Enríquez-Flores S; Castillo-Rodríguez RA; Cárdenas-Rodríguez N; Wong-Baeza C; Baeza-Ramírez I; Gómez-Manzo S
Molecules; 2022 Dec; 27(24):. PubMed ID: 36558035
[TBL] [Abstract][Full Text] [Related]
55. Variability and variation in drug susceptibility among Giardia duodenalis isolates and clones exposed to 5-nitroimidazoles and benzimidazoles in vitro.
Argüello-García R; Cruz-Soto M; Romero-Montoya L; Ortega-Pierres G
J Antimicrob Chemother; 2004 Oct; 54(4):711-21. PubMed ID: 15347633
[TBL] [Abstract][Full Text] [Related]
56. Evaluation of the effects of albendazole and metronidazole on the ultrastructure of Giardia duodenalis, Trichomonas vaginalis and Spironucleus muris using transmission electron microscopy.
Oxberry ME; Thompson RC; Reynoldson JA
Int J Parasitol; 1994 Aug; 24(5):695-703. PubMed ID: 7928072
[TBL] [Abstract][Full Text] [Related]
57. Impaired parasite attachment as fitness cost of metronidazole resistance in Giardia lamblia.
Tejman-Yarden N; Millman M; Lauwaet T; Davids BJ; Gillin FD; Dunn L; Upcroft JA; Miyamoto Y; Eckmann L
Antimicrob Agents Chemother; 2011 Oct; 55(10):4643-51. PubMed ID: 21825286
[TBL] [Abstract][Full Text] [Related]
58. Biological variability of Trichomonas vaginalis clinical isolates from symptomatic and asymptomatic patients.
Hussien EM; El-Sayed HZ; Shaban MM; Salm AM; Rashwan M
J Egypt Soc Parasitol; 2004 Dec; 34(3):979-88. PubMed ID: 15587322
[TBL] [Abstract][Full Text] [Related]
59. Metronidazole and albendazole susceptibility of 11 clinical isolates of Giardia duodenalis from France.
Lemée V; Zaharia I; Nevez G; Rabodonirina M; Brasseur P; Ballet JJ; Favennec L
J Antimicrob Chemother; 2000 Nov; 46(5):819-21. PubMed ID: 11062206
[TBL] [Abstract][Full Text] [Related]
60. [In vitro susceptibility of Trichomonas vaginalis to metronidazole, ornidazole and proton pump inhibitors pantoprazole and esomeprazole].
Aksoy Gökmen A; Girginkardeşler N; Kilimcioğlu AA; Şirin MC; Özbilgin A
Mikrobiyol Bul; 2016 Jan; 50(1):133-9. PubMed ID: 27058337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
